Compare EBMT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EBMT | STXS |
|---|---|---|
| Founded | 1922 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.5M | 164.1M |
| IPO Year | 2009 | 2004 |
| Metric | EBMT | STXS |
|---|---|---|
| Price | $23.43 | $1.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $24.00 | $4.00 |
| AVG Volume (30 Days) | 34.7K | ★ 1.2M |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | ★ 53.23 | 16.67 |
| EPS | ★ 0.98 | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | N/A | $28.22 |
| Revenue Next Year | $5.00 | $30.47 |
| P/E Ratio | $24.31 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.80 | $1.24 |
| 52 Week High | $24.66 | $3.59 |
| Indicator | EBMT | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 45.92 |
| Support Level | $22.68 | N/A |
| Resistance Level | $24.19 | $1.97 |
| Average True Range (ATR) | 0.81 | 0.09 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 38.43 | 72.22 |
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.